Arkansas Administrative Code
Agency 060 - STATE MEDICAL BOARD
Rule 060.00.01-003 - Amendment to Regulation 7 Regulating the Prescribing of Amphetamines and Amphetamine Type Drugs for Narcolepsy, hyperkinesis, or Attention Deficit Disorder

(1) Schedule II Amphetamine, its salts, optical isomers, and salts of its optical isomers;

(2) Schedule II Methamphetamine, its salts, isomers, and salts of its isomers; must comply with both state and federal laws. In addition, prescriptions for theses controlled drugs may be written by a physician only for the treatment of Narcolepsy or Hyperkinesis or Attention Deficit Disorder with or without hyperactivity. No second or subsequent prescription for these controlled drugs may be written for the patient until a second opinion is obtained from a physician confirming (1) the diagnosis of Narcolepsy or Hyperkinesis or Attention Deficit Disorder with or without hyperactivity and (2) that the controlled drug is the drug of choice.

Upon application to the Board and upon demonstration of need, any physician who demonstrates a knowledge in the treatment of Hyperkinesis, Narcolepsy, or Attention Deficit Disorder with or without hyperactivity, may obtain exemption from the second opinion requirement of this regulation including the confirmation of the diagnosis of Narcolepsy, Hyperkinesis, or Attention Deficit Disorder and that the controlled drug is the drug of choice. The Board shall maintain a register of all licensed physicians thus exempted.

Violations of this regulation will be interpreted by the Board as the physician exhibiting gross negligence or ignorant malpractice and shall subject the physician to all penalties provided by Arkansas Code Ann. 17-95-410.